Harumi K, Ohta A, Sato T, Yazaki Y, Tsutsumi T
Division of Cardiology, Showa University Fujigaoka Hospital, Yokohama, Japan.
Jpn Circ J. 1988 Mar;52(3):243-8. doi: 10.1253/jcj.52.243.
We evaluated the effects of antiarrhythmic drugs on ventricular fibrillation threshold (VFT) by analysing the electrophysiologic parameters obtained from strength-interval curves. The VFT determined by low intensity train pulses was significantly increased from the control value under the administration of clinical dosage of procainamide, lidocaine, propranolol, bepridil and prenylamine, although not verapamil. The elevation of VFT could be explained by changes in the strength-interval curve induced by the drugs, including disappearance of dip phenomenon, supernormal period, prolongation of effective refractory period (ERP) and elevation of end diastolic threshold (EDT).
我们通过分析从强度-间期曲线获得的电生理参数,评估了抗心律失常药物对心室颤动阈值(VFT)的影响。在给予普鲁卡因胺、利多卡因、普萘洛尔、苄普地尔和普尼拉明临床剂量时,由低强度串刺激脉冲测定的VFT较对照值显著升高,而维拉帕米则不然。VFT的升高可以通过药物引起的强度-间期曲线变化来解释,包括负性阶梯现象、超常期消失、有效不应期(ERP)延长和舒张末期阈值(EDT)升高。